Anti-TNF agents linked to shingles risk with rheumatoid arthritis

01/10/2013 | MedPage Today (free registration)

Rheumatoid arthritis patients who took anti-tumor necrosis factor drugs such as etanercept, infliximab and adalimumab had a significantly greater risk of developing shingles than those on disease-modifying antirheumatic drugs, according to a study of more than 15,000 patients in the U.K. The findings appeared in the journal Annals of the Rheumatic Diseases.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations